Search

Your search keyword '"El Yafi, S"' showing total 11 results
Start Over Author "El Yafi, S"
11 results on '"El Yafi, S"'

4. Influence of immunosuppressive treatment on the endocrine function of segmental pancreatic allografts

Author

Traeger J, Dubernard JM, Pozza G, SECCHI, ANTONIO, Pontiroli AE, Touraine JL, Betuel H, El Yafi S, Da Ponte F, Cantarovich D, Diab N, Cardozo C, Martin X, Kamel G, Gelet A., BOSI , EMANUELE, Traeger, J, Dubernard, Jm, Pozza, G, Bosi, Emanuele, Secchi, Antonio, Pontiroli, Ae, Touraine, Jl, Betuel, H, El Yafi, S, Da Ponte, F, Cantarovich, D, Diab, N, Cardozo, C, Martin, X, Kamel, G, and Gelet, A.

Published
1983

9. Progress in segmental neoprene-injected pancreas transplantation. Advantages and disadvantages of using Cyclosporin A.

Author

Traeger J, Dubernard JM, Bosi E, Gelet A, El Yafi S, Secchi A, Cardozo C, and Touraine JL

Subjects
Adult, Cyclosporins adverse effects, Diabetes Mellitus, Type 1 therapy, Diabetic Nephropathies therapy, Humans, Kidney drug effects, Kidney Failure, Chronic therapy, Kidney Transplantation, Neoprene administration & dosage, Cyclosporins therapeutic use, Pancreas Transplantation
Abstract

We performed 39 neoprene-injected pancreatic transplants (38 segmental and 1 total) in 37 insulin-dependent diabetic recipients from October 1976 to May 1983. The best results were obtained when the pancreas was transplanted simultaneously with the kidney (25 cases). The use of Cyclosporin A (CyA) for immunosuppression did not reduce the early pancreatic failures, but it seems to have slightly improved the long-term survival. The glycaemic control was better in patients treated by CyA alone than in those receiving steroids. The main side effects of CyA were nephrotoxicity and some immunoglobulin abnormalities with or without lymphoproliferative disorders occurring after treatment with CyA and ALG.

Published
1983

10. Patient selection and risk factors in organ transplantation in diabetics: experience with kidney and pancreas.

Author

Traeger J, Dubernard JM, Bosi E, Piatti PM, Gelet A, El Yafi S, Beutel H, Secchi A, Touraine JL, and Pozza G

Subjects
Actuarial Analysis, Adult, Diabetic Nephropathies mortality, Humans, Kidney Failure, Chronic mortality, Middle Aged, Postoperative Complications mortality, Preoperative Care, Retrospective Studies, Risk, Diabetic Nephropathies therapy, Kidney Failure, Chronic therapy, Kidney Transplantation, Pancreas Transplantation
Published
1984

11. Deferoxamine for the diagnosis and treatment of aluminum-associated osteodystrophy.

Author

Charhon S, el Yafi S, Gaillard M, Beruard M, Janin G, Accominotti M, Traeger J, and Meunier PJ

Subjects
Adult, Aluminum blood, Aluminum metabolism, Chronic Kidney Disease-Mineral and Bone Disorder drug therapy, Chronic Kidney Disease-Mineral and Bone Disorder etiology, Female, Humans, Infusions, Intravenous, Male, Parathyroid Hormone blood, Renal Dialysis adverse effects, Aluminum adverse effects, Chronic Kidney Disease-Mineral and Bone Disorder diagnosis, Deferoxamine administration & dosage, Deferoxamine therapeutic use
Published
1988
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results